How can pharmaceutical companies develop leaders in quality? What is the relationship between data integrity and quality culture? How can FDA assess quality in manufacturing?
In conjunction with Quality Week, Redica Systems is releasing our latest report, “The Current Pharmaceutical Landscape.” Written by Jerry Chapman, Redica’s Senior GMP Quality Expert, and drawing on his coverage of industry conferences, the four articles contained in the report address the topics of data integrity and quality culture, FDA’s Quality Maturity Model, and training on quality.
What You Will Learn
- How a major pharmaceutical company designed a program to train future leaders in quality
- An industry-led initiative to advance the state of quality in the pharma industry
- A pharma GMP leader’s tips for supporting quality culture within an organization
- An update on FDA’s Quality Maturity Model
You can access the Redica Systems report, “The Current Pharmaceutical Quality Landscape,” here.
About the Expert
Jerry Chapman is a Senior GMP Quality Expert at Redica Systems. He brings 40 years’ experience in the pharma industry, including 31 years at Eli Lilly in technical and leadership positions in research and product development, manufacturing, plant quality, site quality, corporate quality, and quality systems.
Subscribe to Redica Insights
Get quality and compliance insights from our experts in your inbox